Vertex Pharma stock gains 3.19% since report as FDA date nears


Scotiabank keeps USD 558.00 target for Vertex Pharma stock ...

Vertex Pharmaceuticals advances povetacicept: what it means ...

Benzinga cites a USD 544.00 target for Vertex Pharmaceuticals ...

Vertex Pharma publishes kidney results as Vertex Pharma ...

Vertex Pharma stock pre-market at EUR 467.88: biotech company ...

Vertex Pharma stock trades at EUR 469.05 in weekend trading ...

Vertex Pharma reports RAINIER results as Vertex Pharma stock ...

Vertex Pharma stock: Citi keeps Buy rating at USD 585.00 ...

Wall Street Zen upgrades Vertex Pharmaceuticals stock to ...